News & media

  • PRESS RELEASE

    Zealand Pharma announces initiation of the registrational Phase 3 ZUPREME program of petrelintide in people with overweight or obesity

  • COMPANY ANNOUNCEMENT

    Zealand Pharma - Transactions related to share buy-back program (week 38, 2026)

  • PRESS RELEASE

    Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome

  • COMPANY ANNOUNCEMENT

    Zealand Pharma - Transactions related to share buy-back program (week 37, 2026)

  • COMPANY ANNOUNCEMENT

    Zealand Pharma increases its share capital as a result of the exercise of employee warrants

  • PRESS RELEASE

    Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference

  • COMPANY ANNOUNCEMENT

    Zealand Pharma - Transactions related to share buy-back program (week 36, 2026)

  • COMPANY ANNOUNCEMENT

    Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)

  • COMPANY ANNOUNCEMENT

    Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)

  • COMPANY ANNOUNCEMENT

    Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

  • COMPANY ANNOUNCEMENT

    Zealand Pharma – Notification of holding of treasury shares

  • COMPANY ANNOUNCEMENT

    Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)

Corporate management

  • Adam ALR0640

    Adam Steensberg - President and Chief Executive Officer

  • Zealand Pharma 0285 FIN

    Adam Steensberg - President and Chief Executive Officer

  • Adam ALR0631

    Adam Steensberg - President and Chief Executive Officer

  • Henriette ALR0758

    Henriette Wennicke - Executive Vice President and Chief Financial Officer

  • Christina ALR0693 V2

    Christina Sonnenborg Bredal - Executive Vice President and Chief People Officer

  • David ALR1003

    David Kendall - Executive Vice President, Research & Development and Chief Medical Officer

  • Ivan ALR0873

    Ivan Møller - Executive Vice President and Chief Operating Officer

  • Utpal Singh 1

    Utpal Singh - Executive Vice President and Chief Scientific Officer

  • Utpal Singh 2

    Utpal Singh - Executive Vice President and Chief Scientific Officer

  • Steven Johnson

    Steven Johnson - Executive Vice President, Chief Development Officer

  • Eric Cox ALR8394

    Eric Cox - Executive Vice President, Chief Commercial Officer

Research and development

Sustainability

Logos and icons

Zealand Pharma 1503

Stay up-to-date with the latest news from Zealand

Sign-up to receive press releases and company announcements directly to your inbox

Subscribe to news

Investor and Media contacts